1-5 of 5
Karen Rosell, BS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phenotypic, Genotypic, and Functional Characterization Of AML-Derived Endothelial Cells

Russell J Pizzo, Myra Coppage, PhD, Karen Rosell, BS, Kimberly Morse, MS, Jane L. Liesveld, MD
Journal: Blood
Blood (2013) 122 (21): 1411.
https://doi.org/10.1182/blood.V122.21.1411.1411
Published: 2013
Journal Articles

Phase I Study of Decitabine and Rapamycin in Relapsed/Refractory Acute Myelogenous Leukemia

Jane L. Liesveld, MD, Kristen O'Dwyer, MD, Michael W. Becker, MD, Deborah Mulford, MD, Alison Walker, MD, Rui Chen, PhD, Jeremy Bechelli, MS, Karen Rosell, BS, Craig T. Jordan, PhD, Mohammad Minhajuddin, PhD, Gordon L. Phillips, II, MD
Journal: Blood
Blood (2012) 120 (21): 3549.
https://doi.org/10.1182/blood.V120.21.3549.3549
Published: 2012
Journal Articles

Activity and Cytotoxicity of Algae Extracts On Normal and Leukemic Hematopoietic Cells.

Jeremy Bechelli, M.S., Karen Rosell, BS, Myra Coppage, PhD, Jane Liesveld, MD
Journal: Blood
Blood (2009) 114 (22): 4815.
https://doi.org/10.1182/blood.V114.22.4815.4815
Published: 2009
Journal Articles

Enrichment of CD34+ Hematopoietic Stem and Progenitor Cells from Human Bone Marrow Using a P-Selectin-Coated Microtube.

Srinivas D. Narasipura, PhD, Jane L. Liesveld, MD, Joel C. Wojciechowski, PhD, Nichola Charles, MD, Karen Rosell, BS, Michael R. King, PhD
Journal: Blood
Blood (2007) 110 (11): 1219.
https://doi.org/10.1182/blood.V110.11.1219.1219
Published: 2007
Journal Articles

The mTOR Inhibitor Rapamycin Demonstrates Activity Against AML in Combination with Imatinib Mesylate and with 5-Azacytidine.

Jane L. Liesveld, MD, Karen Rosell, BS, Chaohui Lu, BS, Deborah Mulford, MD, Alison Walker, MD
Journal: Blood
Blood (2007) 110 (11): 4318.
https://doi.org/10.1182/blood.V110.11.4318.4318
Published: 2007